Proteomic profiling based on mass spectrometry is an important tool for studies at the protein and peptide level in medicine and health care. Thereby, the identification of releva...
Frank-Michael Schleif, Thomas Villmann, Barbara Ha...
Abstract. Analysis and visualization of high-dimensional clinical proteomic spectra obtained from mass spectrometric measurements is a complicated issue. We present a wavelet based...
Frank-Michael Schleif, Thomas Villmann, Barbara Ha...
In this article, we extend a local prototype-based learning model by active learning, which gives the learner the capability to select training samples during the model adaptation...
Frank-Michael Schleif, Barbara Hammer, Thomas Vill...
Mass spectrometry from clinical specimens is used in order to identify biomarkers in a diagnosis. Thus, a reliable method for both feature selection and classification is required...
Background: Pancreatic cancer is the fourth leading cause of cancer death in the United States. Consequently, identification of clinically relevant biomarkers for the early detect...